Inhibition of hepatitis C virus protein expression by RNA interference (Q40638524)

22 September 2017

Inhibition of hepatitis C virus protein expression by RNA interference (English)

1 reference

22 September 2017

1 reference

1 reference

6

Ratna B Ray

1 reference

22 September 2017

Adrish Sen

1

1 reference

22 September 2017

Robert Steele

2

1 reference

22 September 2017

Asish K Ghosh

3

1 reference

22 September 2017

Arnab Basu

4

1 reference

22 September 2017

Ranjit Ray

5

1 reference

22 September 2017

1 October 2003

1 reference

22 September 2017

1 reference

22 September 2017

96

1 reference

22 September 2017

1-2

1 reference

22 September 2017

27-35

1 reference

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

In vitro models for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Short interfering RNA confers intracellular antiviral immunity in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus and hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Modulation of HIV-1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Treatment of acute hepatitis C with interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Inhibition of gammaherpesvirus replication by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus particle detected by immunoelectron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Interference of hepatitis C virus RNA replication by short interfering RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Cytokines in viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

RNAi targeting an animal virus: news from the front

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

RNA interference in adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Current and evolving therapies for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

siRNA-directed inhibition of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Persistent and transient replication of full-length hepatitis C virus genomes in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis viruses: changing patterns of human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Small Interfering RNA-Mediated Inhibition of Hepatitis C Virus Replication in the Human Hepatoma Cell Line Huh-7

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

RNA interference--2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

siRNA-mediated gene silencing in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

RNA interference: listening to the sound of silence

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2803%2900170-9

7 January 2021

10.1016/S0168-1702(03)00170-9

Identifiers

DOI

1 reference

22 September 2017

1 reference